Fig. 2. Changes in Barhl2 levels alter neural plate formation. (A)
Sequence comparison between the Eh1 motifs of Gsc, Eng, Nkx, Anf-1, Hesx1 and
Msx, and the FILs domains of Barhl proteins. Black shading indicates identical
residues, gray shading indicates similarity. Most of the sequences, except for
Barhl members, come from Smith and Jaynes
(Smith and Jaynes, 1996). (B)
Map of the RNA constructs. The two blue boxes indicate the FIL domains; the
green box indicates the Myc epitope; the yellow box indicates the Engrailed
repression domain. (C) Sequences of the Xbarhl2 antisense
morpholinos. The five mispairs in Xbarhl2ASIII are in red and the ATG
is in bold. For comparison, the N-terminal sequences of mouse Barhl2,
Xbarhl1 and Xbarhl2 are shown. (D) In situ hybridization of
embryos injected with mouse Barhl2, Barhl2
FIL,
Barhl2
FIL-enR, Xbarhl2ASI, Xbarhl2ASII, Xbarhl2ASIII and analyzed
at stage 15. Dorsal view, anterior end upwards. The broken line indicates the
midline and `inj' indicates the injected side. Embryos labeled with
Xsox3 as probe: (a) control; injected with mouse Barhl2 at
(b) 10 pg and (c) 50 pg; (e) injected with mouse Barhl2
FIL
(100 pg); (f) injected with mouse Barhl2
FIL-enR (50 pg); (g)
injected with Xbarhl2ASI; (h) injected with Xbarhl2ASII;
injected with Xbarhl2ASII at (i) 20 ng, (j) 50 ng and (k) 100 ng.
Embryos labeled with XK81 as a probe: injected with mouse
Barhl2 at 10 pg (d); injected with Xbarhl2ASII (l). (E)
Two-cell embryos were injected in one blastomere and analyzed at stage 9.
Representative embryos are shown under fluorescent light. (a) Embryos injected
with Xbarhl2-myc (100 pg); (b) injected with Xbarhl2-myc
(100 pg) together with Xbarhl2ASII (100 ng); (c) injected with
Xbarhl2-myc (100 pg) together with Xbarhl2ASIII (100 ng).
(F) Western analysis on protein extracts from stage 9 embryos injected with
Xbarhl2-myc (100 pg) together with: Xbarhl2ASIII (100 ng)
(a); Xbarhl2ASII (50 ng) (b) or Xbarhl2ASII (100 ng)
(b') using anti-Myc antibody. (G) Embryos labeled with Xsox3 as
probe. The percentage of embryos exhibiting the staining patterns: (a)
injected with mouse Barhl2 (10 pg), 78%; (b) injected with
Xbarhl2ASII (50 ng), 88%; (c) injected with mouse Barhl2 (10
pg) together with Xbarhl2ASII (50 ng), 60%.